Market Fallers: Burberry Group plc, GlaxoSmithKline plc, AstraZeneca plc, HSBC Holdings plc, Imperial Brands PLC & Informa PLC

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Shares in Burberry Group plc ticker code: LON:BRBY has dropped -2.58% or -51 points throughout the session so far. Investors have not remained optimistic while the stock has been in play. The periods high figure was 1983 dipping to 1922. The total volume traded so far comes to 417,570 while the average shares exchanged is 1,375,066. The 52 week high price for the shares is 2338 which comes in at 362 points different to the previous business close and a 52 week low sitting at 1526.5 which is a variance of 449.5 points. Burberry Group plc has a 20 SMA of 1916.78 and a 50 day simple moving average now at 1829.87. The current market capitalisation is £7,919.37m at the time of this report. The share price is in GBX. Mcap is measured in GBP. This article was written with the last trade for Burberry Group plc being recorded at Tuesday, February 26, 2019 at 12:02:17 PM GMT with the stock price trading at 1925.5 GBX.

 

Shares of GlaxoSmithKline plc ticker code: LON:GSK has decreased -1.94% or -28.4 points during the course of today’s session so far. Sellers were not positive during the trading session. The periods high has already touched 1525.8 and hitting a low of 1500.5. Volume total for shares traded during this period was 1,983,518 whilst the average number of shares exchanged is 8,433,355. The stock 52 week high is 1648.8 amounting to 114.4 points difference from the previous days close and putting the 52 week low at 1179.39 which is a variance of 355.01 points. GlaxoSmithKline plc now has a 20 SMA of 1543.56 and now the 50 day SMA of 1524.85. This puts the market capitalisation now at £74,732.01m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for GlaxoSmithKline plc being recorded at Tuesday, February 26, 2019 at 11:59:48 AM GMT with the stock price trading at 1506 GBX.

 

Shares of AstraZeneca plc found using EPIC: LON:AZN has declined -1.61% or -101 points during today’s session so far. Sellers did not seem confident during the trading session. Range high for the period so far is 6281 and hitting a low of 6153. Volume total for shares traded during this period was 569,936 while the average shares exchanged is 2,516,232. The 52 week high is 6432.48 some 142.48 points difference from the previous days close and putting the 52 week low at 4715 a difference of some 1575 points. AstraZeneca plc now has a 20 moving average of 5874.85 and also a 50 day moving average of 5844.68. The market cap now stands at £78,420.91m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for AstraZeneca plc being recorded at Tuesday, February 26, 2019 at 12:02:13 PM GMT with the stock price trading at 6189 GBX.

 

Shares of HSBC Holdings plc company symbol: LON:HSBA has decreased -1.71% or -10.6 points during the course of today’s session so far. Traders did not seem confident throughout the trading session. The periods high has already touched 619.8 dipping to 609.9. The total volume of shares exchanged so far has reached 9,088,274 with the daily average traded share volume around 21,987,123. A 52 week share price high is 749.9 equating to 128.3 points different to the previous business close and a 52 week low sitting at 596.4 making a difference of 25.2 points. HSBC Holdings plc now has a 20 SMA at 650.87 and now a 50 day moving average of 650.14. Market capitalisation for the company is £122,541.26m at the time of this report. The currency for this stock is GBX. Market cap is measured in GBP. This article was written with the last trade for HSBC Holdings plc being recorded at Tuesday, February 26, 2019 at 12:02:13 PM GMT with the stock price trading at 611 GBX.

 

Shares of Imperial Brands PLC with company EPIC: LON:IMB has stepped down -1.88% or -49 points during today’s session so far. Market sellers were not positive throughout the session. The period high was 2595 and hitting a low of 2547. The total volume of shares exchanged so far has reached 460,357 while the daily average number of shares exchanged is 2,162,630. The stock 52 week high is 3009 which is 409 points difference from the previous close and the 52 week low at 2239.5 a difference of some 360.5 points. Imperial Brands PLC now has a 20 SMA at 2600.5 with a 50 day moving average now of 2497.56. Market capitalisation for the company is £24,406.36m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for Imperial Brands PLC being recorded at Tuesday, February 26, 2019 at 11:59:51 AM GMT with the stock price trading at 2551 GBX.

 

The share price for Informa PLC with company EPIC: LON:INF has decreased -1.69% or -12.2 points during today’s session so far. Sellers aired on the negative side during the trading session. The high for the period has peaked at 719.6 dropping as low as 709.8. The total volume of shares exchanged through this period comes to 296,112 while the daily average number of shares exchanged is 4,733,839. The stock 52 week high is 869.6 which comes in at 147.6 points in difference to the previous days close of business and a 52 week low sitting at 602.8 making a difference of 119.2 points. Informa PLC has a 20 day moving average of 703.96 with a 50 day moving average now of 673.8. The market cap now stands at £8,885.27m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Informa PLC being recorded at Tuesday, February 26, 2019 at 12:02:16 PM GMT with the stock price trading at 709.8 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    GSK reports success in phase III trial of Zejula and Jemperli for advanced ovarian cancer, achieving significant progression-free survival improvement.
    GSK's Jemperli receives FDA Breakthrough Therapy Designation for treating locally advanced dMMR/MSI-H rectal cancer, expediting crucial development.
    GSK announces FDA review of Nucala for COPD treatment following successful MATINEE study data, aiming to be the first approved monthly biologic.

      Search

      Search